PTEN(磷酸酶和张力蛋白同源物)是一种重要的抑癌基因,位于人类10号染色体(10q23.3),编码一种具有双重特异性磷酸酶活性的蛋白质。PTEN蛋白的主要功能是通过其脂质磷酸酶活性负调控PI3K/AKT/mTOR信号通路,将PIP3(磷脂酰肌醇-3,4,5-三磷酸)去磷酸化为PIP2(磷脂酰肌醇-4,5-二磷酸),从而抑制细胞增殖、存活和代谢。此外,PTEN还具有蛋白磷酸酶活性,可调节细胞迁移和黏附。PTEN在多种组织中广泛表达,尤其在脑、前列腺和子宫内膜中表达较高。PTEN的突变或缺失会导致PI3K/AKT/mTOR通路过度激活,促进细胞异常增殖和肿瘤发生。PTEN突变与多种癌症密切相关,如胶质母细胞瘤、前列腺癌、子宫内膜癌和乳腺癌等。此外,PTEN突变还与遗传性疾病如PTEN错构瘤综合征(包括Cowden综合征和Bannayan-Riley-Ruvalcaba综合征)相关,这些疾病表现为多发性错构瘤、自闭症谱系障碍和智力障碍。PTEN属于蛋白酪氨酸磷酸酶(PTP)基因家族,该家族成员通过去磷酸化底物蛋白调控细胞信号转导。PTEN过表达会过度抑制PI3K/AKT/mTOR通路,导致细胞凋亡增加和生长抑制,而PTEN表达降低或缺失则会导致AKT过度激活,促进肿瘤发生和转移。PTEN还与其他基因如TP53和CDKN1A相互作用,共同调控细胞周期和基因组稳定性。研究表明,PTEN在干细胞维持、衰老和免疫调节中也发挥重要作用。因此,PTEN是癌症治疗的重要靶点,针对PTEN缺失肿瘤的PI3K/AKT/mTOR抑制剂正在研发中。
This gene was identified as a tumor suppressor that is mutated in a large number of cancers at high frequency. The protein encoded by this gene is a phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase. It contains a tensin like domain as well as a catalytic domain similar to that of the dual specificity protein tyrosine phosphatases. Unlike most of the protein tyrosine phosphatases, this protein preferentially dephosphorylates phosphoinositide substrates. It negatively regulates intracellular levels of phosphatidylinositol-3,4,5-trisphosphate in cells and functions as a tumor suppressor by negatively regulating AKT/PKB signaling pathway. The use of a non-canonical (CUG) upstream initiation site produces a longer isoform that initiates translation with a leucine, and is thought to be preferentially associated with the mitochondrial inner membrane. This longer isoform may help regulate energy metabolism in the mitochondria. A pseudogene of this gene is found on chromosome 9. Alternative splicing and the use of multiple translation start codons results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Feb 2015]
该基因被确定为是在以高频率的大量癌症中突变的肿瘤抑制。由该基因编码的蛋白质是一个磷脂酰肌醇-3,4,5-三磷酸酯-3-磷酸酶。它包含象域的张力蛋白以及类似于双重特异性蛋白酪氨酸磷酸酶的催化??结构域。不像一般的蛋白酪氨酸磷酸酶的,该蛋白质优选脱磷酸化的磷酸肌醇底物。它负面AKT / PKB信号传导途径负调节细胞和用作抑癌磷脂酰-3,4,5-三磷酸酯的细胞内水平调节。使用非规范(CUG)上游起始位点的产生可启动翻译用亮氨酸较长同种型,并且被认为与线粒体内膜优先相关联。这不再亚型可能有助于调节线粒体能量代谢。该基因的假基因是在9号染色体可变剪接发现和使用多个翻译起始密码子在多个成绩单结果变种编码不同亚型。 [由RefSeq的,2015年2月提供]
PTEN基因(以及对应的蛋白质)的细胞分布位置:
PTEN基因的本体(GO)信息:
名称 |
---|
562 Inositol phosphate metabolism [PATH:hsa00562] |
4068 FoxO signaling pathway [PATH:hsa04068] |
4070 Phosphatidylinositol signaling system [PATH:hsa04070] |
4071 Sphingolipid signaling pathway [PATH:hsa04071] |
4151 PI3K-Akt signaling pathway [PATH:hsa04151] |
4150 mTOR signaling pathway [PATH:hsa04150] |
4115 p53 signaling pathway [PATH:hsa04115] |
4510 Focal adhesion [PATH:hsa04510] |
4530 Tight junction [PATH:hsa04530] |
5200 Pathways in cancer [PATH:hsa05200] |
5230 Central carbon metabolism in cancer [PATH:hsa05230] |
5206 MicroRNAs in cancer [PATH:hsa05206] |
5214 Glioma [PATH:hsa05214] |
5218 Melanoma [PATH:hsa05218] |
5215 Prostate cancer [PATH:hsa05215] |
5213 Endometrial cancer [PATH:hsa05213] |
5222 Small cell lung cancer [PATH:hsa05222] |
5161 Hepatitis B [PATH:hsa05161] |
名称 |
---|
Adaptive Immune System |
DAP12 interactions |
DAP12 signaling |
Downstream signal transduction |
Downstream signaling events of B Cell Receptor (BCR) |
Downstream signaling of activated FGFR1 |
Downstream signaling of activated FGFR2 |
Downstream signaling of activated FGFR3 |
Downstream signaling of activated FGFR4 |
Downstream TCR signaling |
Fc epsilon receptor (FCERI) signaling |
GAB1 signalosome |
Gene Expression |
Generic Transcription Pathway |
Immune System |
Innate Immune System |
Inositol phosphate metabolism |
Metabolism of lipids and lipoproteins |
Negative regulation of the PI3K/AKT network |
NGF signalling via TRKA from the plasma membrane |
Phospholipid metabolism |
PI Metabolism |
PI-3K cascade:FGFR1 |
PI-3K cascade:FGFR2 |
PI-3K cascade:FGFR3 |
PI-3K cascade:FGFR4 |
PI3K events in ERBB2 signaling |
PI3K events in ERBB4 signaling |
PI3K/AKT activation |
PIP3 activates AKT signaling |
Role of LAT2/NTAL/LAB on calcium mobilization |
Signaling by EGFR |
Signaling by ERBB2 |
Signaling by ERBB4 |
Signaling by FGFR |
Signaling by FGFR1 |
Signaling by FGFR2 |
Signaling by FGFR3 |
Signaling by FGFR4 |
Signaling by PDGF |
Signaling by SCF-KIT |
Signaling by the B Cell Receptor (BCR) |
Signalling by NGF |
Synthesis of IP3 and IP4 in the cytosol |
Synthesis of PIPs at the plasma membrane |
TCR signaling |
TP53 Regulates Metabolic Genes |
Transcriptional Regulation by TP53 |
疾病名称 | 关系值 | NofPmids | NofSnps | 来源 |
MACROCEPHALY/AUTISM SYNDROME | 0.56 | 1 | 9 | CLINVAR_CTD_human_MGD_ORPHANET_UNIPROT |
Hamartoma Syndrome, Multiple | 0.521446 | 208 | 1 | BeFree_CTD_human_GAD_LHGDN_MGD_ORPHANET_UNIPROT |
Squamous cell carcinoma of the head and neck | 0.482985861 | 12 | 1 | BeFree_CLINVAR_CTD_human_ORPHANET_UNIPROT |
Bannayan-Riley-Ruvalcaba Syndrome | 0.454386419 | 54 | 8 | BeFree_CLINVAR_MGD_ORPHANET_UNIPROT |
Endometrial Carcinoma | 0.358197359 | 133 | 2 | BeFree_CLINVAR_GAD_MGD_UNIPROT |
melanoma | 0.272069867 | 80 | 5 | BeFree_CLINVAR_CTD_human_LHGDN |
Malignant neoplasm of prostate | 0.263876054 | 185 | 0 | BeFree_GAD_MGD_UNIPROT |
Meningioma | 0.245819831 | 7 | 1 | BeFree_CLINVAR_CTD_human_GAD |
Proteus Syndrome | 0.245167327 | 12 | 0 | BeFree_CTD_human_LHGDN_ORPHANET |
Lhermitte-Duclos disease | 0.243257302 | 12 | 3 | BeFree_CLINVAR_ORPHANET |
关注微信订阅号,实时查看信息,关注医学生物学动态。